Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Envision Healthcare Holdings, Inc. (“Envision” or the “Company”) (NYSE: EVHC). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
If you purchased shares of Envision during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
On October 22, 2015, Envision reported third quarter earnings of $17.2 million, which fell short of Wall Street’s expectations. The Company stated that it had net income of $.09 cents per share. Earnings, adjusted for restructuring costs and amortization costs, were $.30 cents per share.
If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151023005976/en/
Contacts:
Joon M. Khang, Esq.
Telephone:
949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com
